Artiva Biotherapeutics, Inc.

ARTV·NasdaqGM·Healthcare
Compare
4.2200+0.0200 (+0.48%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.2000
Open4.2500
Day range4.16004.2700
52-week range2.960014.5300
Off day high−1.17%
Off 52-week high−70.96%
Volume754.02K
Avg. volume (3M)641.15K
Market cap206.32M
EPS (TTM)-3.23
Forward P/E-2.13
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.68
Shares outstanding48.89M
Short interest11.05% of float
Earnings dateNov 12, 2026 (est.)
Analyst target20.7500
Profit margin0.00%

Against its peers

Compare in full ›
ARTV NKTX ACRS CHRS IPHA CRVS
Market cap 206.32M 123.91M 570.34M 131.36M 159.17M 889.16M
P/E (TTM) — — — — — —
Forward P/E -2.1 -1.0 -5.1 -1.3 -3.0 -9.9
Price/book 0.6 0.5 4.1 2.2 -2.9 3.9
Dividend yield — — — — — —
1-year change +22.67% −12.18% +62.11% −42.95% −20.83% +35.17%
Today +0.48% +13.07% −1.60% +5.54% +5.56% +7.53%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ARTV news ›
Hoodline·Negative

Artiva Biotherapeutics Cuts 94% of Staff in San Diego

Artiva Biotherapeutics is abandoning its lead experimental cell therapy and slashing roughly 94% of its workforce after two patients died during a clinical trial testing the treatment for autoimmune disease. The San Diego-based company,…

Seeking Alpha·Negative

Artiva slumps after discontinuing lead asset

Artiva Biotherapeutics (ARTV) stock plunged after fatal trial events prompted the company to discontnue its lead canddiate AlloNK and layoff staff. Read more here. Artiva Biotherapeutics (ARTV) lost more than 30% in premarket trading on…

From the 4Search news index, newest first.

In the news

17mentions in 30 days
11with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance